Get all your news in one place.
100's of premium titles.
One app.
Start reading

FiberSense Continuous Glucose Monitoring (CGM) System obtains CE mark as commercial launch preparations begin

Major regulatory milestone paves the way for commercialization and marks first step toward broader CxM biomarker sensing strategy

BASEL, Switzerland, June 17, 2026 /PRNewswire/ -- FiberSense AG ("FiberSense") today announced that the FiberSense Continuous Glucose Monitoring (CGM) System has obtained CE marking under Regulation (EU) 2017/745 as a Class IIb medical device.

FiberSense obtains CE marking for its new CGM System, designed to support continuous glucose monitoring in everyday life
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.